Intention and hesitancy to receive a booster dose of COVID-19 vaccine among pregnant women using a health belief model: A cross-sectional study
dc.authorid | ALTAIE, Anmar/0000-0002-2183-6830 | |
dc.authorwosid | ALTAIE, Anmar/ITV-8235-2023 | |
dc.contributor.author | Al-Taie, Anmar | |
dc.contributor.author | Yilmaz, Zekiye | |
dc.contributor.author | Cakiroglu, Ahmet Yigit | |
dc.contributor.author | Candan, Gulnihal | |
dc.contributor.author | Bildirici, Selin | |
dc.date.accessioned | 2024-05-19T14:39:32Z | |
dc.date.available | 2024-05-19T14:39:32Z | |
dc.date.issued | 2023 | |
dc.department | İstinye Üniversitesi | en_US |
dc.description.abstract | Objective: To examine the pattern of COVID-19 infection and vaccination, and to explore pregnant women's willingness and reluctance to accept a booster dose of the COVID-19 vaccine.Methods: This was a cross-sectional, descriptive study with a convenient sample size using a structured questionnaire among pregnant women attending the gynecology and obstetrics department at Acibadem Mehmet Ali Aydinlar Hospital, Istanbul, Turkiye. The Health Belief Model scale was used to assess the intention and reluctance to accept a booster dose of the COVID-19 vaccine.Results: A total of 145 participants, with a mean age of (33.5 +/- 4.8) years, and a gestational age of (30.9 +/- 7.3) weeks, were enrolled in this study. 88.8% Received full doses of the Pfizer-BioNTech vaccination. 47.8% Participants suffered from vaccine adverse effects. Health Belief Model demonstrated a significant finding of perceived susceptibility (P<0.001), perceived severity of COVID-19 complications (P<0.001), and perceived benefits regarding a booster COVID-19 vaccination (P<0.001).Conclusions: Most pregnant women who received the COVID-19 immunization express a significant intention to receive a booster dose, regardless of the adverse effects experienced from the previous doses. However, a small percentage of the study sample express hesitancy about receiving the booster dose. | en_US |
dc.identifier.doi | 10.4103/2221-6189.388032 | |
dc.identifier.endpage | 185 | en_US |
dc.identifier.issn | 2221-6189 | |
dc.identifier.issn | 2589-5516 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 179 | en_US |
dc.identifier.uri | https://doi.org10.4103/2221-6189.388032 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/4800 | |
dc.identifier.volume | 12 | en_US |
dc.identifier.wos | WOS:001103979600006 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wolters Kluwer Medknow Publications | en_US |
dc.relation.ispartof | Journal of Acute Disease | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | 20240519_ka | en_US |
dc.subject | Booster Dose | en_US |
dc.subject | Hesitancy | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Covid-19 | en_US |
dc.subject | Sars-Cov-2 | en_US |
dc.subject | Vaccine | en_US |
dc.title | Intention and hesitancy to receive a booster dose of COVID-19 vaccine among pregnant women using a health belief model: A cross-sectional study | en_US |
dc.type | Article | en_US |